trial · primary record
JNJ-90009530
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 21 |
| Primary completion | 2040-01-03 |
| Primary endpoint | Calculate the Occurence of Adverse Events |
| Registry ID | NCT05784441 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:48.143Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05784441
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
